ArticleHaematologica2022

In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability.

Naike Casagrande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.